Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0001209191-23-048595

Director sold 2,500 shares at $30.00 ($75,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Scott Randal W. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-05 Sale : show line 1 in the form 10b5-1 −2,500 $30.00 $75,000 13,500 I
Open-market sales · 2,500 sh · avg $30.00 · $75,000
Loading xslF345X05/doc4.xml…